February 10, 2009 - Sorin Group said today it acquired the Clearglide endoscopic vessel harvesting (EVH) product line of Datascope Inc., which enables less-invasive harvesting of vessels for use in coronary artery bypass grafting.
February 10, 2009 - W. L. Gore and Associates today said at the annual International Congress of Endovascular Interventions XXII, it received FDA approval to market a modified version of the GORE TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs).
February 10, 2009 - Hospitals will be eligible in Medicare’s 2009 fiscal year for up to an additional $53,000 in reimbursement when they implant a CardioWest temporary Total Artificial Heart (TAH-t) compared to subsequently transplanting a donor heart.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Codonics Horizon is three imagers in one – a dry film imager, color imager, and grayscale paper imager. Switching between film, color and paper requires no operator intervention. The all-in-one imager aims to provide high quality images while being affordable.
Integrity Disk Importer is designed to be an easy-to-use solution to read, reconcile and store medical studies from a disc into PACS, or allows DICOM images to be stored directly to Integrity from any network device.
February 9, 2009 - Biosense Webster Inc. said Friday the FDA granted market clearance for the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible 3D electroanatomic mapping systems.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 9, 2009 - Implantation of drug-eluting stents to treat degenerative in aortocoronary saphenous vein graft (SVG) lesions is safe, according to a study published in the Jan. 15 issue of the American Journal of Cardiology (Vol. 103, issue 2, Pages 199-202).
February 9, 2009 – Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms, according to findings published in the online edition of Radiology.
February 9, 2009 - Emory University cardiologists are testing a modification of angioplasty known as postconditioning, designed to reduce permanent damage to the heart muscle after a heart attack.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 6, 2009 - Biosense Webster Inc., a Johnson & Johnson company, today said the FDA granted market approval to the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible 3D electroanatomic mapping systems.
February 6, 2009 – The FDA has approved St. Jude Medical Inc.’s medical device system that allows a single defibrillation lead connection between a cardiac resynchronization therapy defibrillator (CRT-D) and the leads that send electrical impulses to the heart to treat the symptoms of heart failure.
February 6, 2009 - Medtronic Inc. today said it completed the acquisition of Ablation Frontiers Inc. for an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 6, 2009 - Boston Scientific Corp. yesterday submitted to the FDA the final modules of the company’s pre-market approval (PMA) applications for both its TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System and its TAXUS Liberte Long Paclitaxel-Eluting Coronary Stent System.
February 6, 2009 - Premier Purchasing Partners yesterday announced new agreements for drug-eluting coronary stents with Abbott Laboratories Inc., Abbott Vascular and Cordis Corp. The 13-month agreements went into effect Jan. 1, 2009 and are available to acute care and continuum of care members of the Premier healthcare alliance.
February 5, 2009 - Resuscitation device maker ZOLL Medical Corp. said this week it filed a lawsuit against Alsius Corp. and Alsius Medical Corp. in the Central District of California alleging infringement of its patents for catheter-based induced hypothermia devices.